(APUE) Trust Professional Managers - Overview
Etf: Etf, Equity, Us Stocks, Active Management
Dividends
| Dividend Yield | 0.82% |
| Yield on Cost 5y | 1.44% |
| Yield CAGR 5y | 70.76% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.4% |
| Relative Tail Risk | 3.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.67 |
| Alpha | 1.24 |
| Character TTM | |
|---|---|
| Beta | 0.917 |
| Beta Downside | 0.929 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.83% |
| CAGR/Max DD | 1.21 |
Description: APUE Trust Professional Managers January 14, 2026
The Trust for Professional Managers Active U.S. Equity ETF (NYSE ARCA: APUE) is an actively-managed fund that blends active and passive tactics to seek lower costs, tighter tracking error, and upside potential relative to its benchmark, the CRSP U.S. Total Market Index. In typical market environments the ETF is required to hold at least 80 % of its net assets (plus any investment-purpose borrowings) in U.S. equities that are constituents of that index.
Key data points as of the latest filing: an expense ratio of 0.15 % (well below the average 0.30 % for large-blend ETFs), assets under management of roughly $250 million, and an average portfolio turnover of 30 % annually, indicating a modest level of active trading. The fund’s sector exposure mirrors the broad market, with the largest allocations to Information Technology (~25 %), Health Care (~14 %), and Consumer Discretionary (~13 %). Macro drivers that will likely influence performance include U.S. consumer spending trends, the Federal Reserve’s policy stance on interest rates, and corporate earnings growth in the technology and health-care segments.
If you want a more granular, data-driven view of APUE’s valuation metrics and risk profile, consider checking out ValueRay’s analytics tools for deeper insight.
What is the price of APUE shares?
Over the past week, the price has changed by +0.21%, over one month by +0.40%, over three months by +4.64% and over the past year by +15.59%.
Is APUE a buy, sell or hold?
What are the forecasts/targets for the APUE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 48.5 | 13.9% |
APUE Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.24b USD (2.24b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.24b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.24b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.30% (E(2.24b)/V(2.24b) * Re(9.30%) + (debt-free company))
Discount Rate = 9.30% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)